A prospective study of the effect of two different forms of iron therapy for women, who diagnosed with iron deficiency anaemia during pregnancy with the aim to achieve a normal haemoglobin level at the time of delivery.
Not Applicable
Completed
- Conditions
- Iron deficiency anaemia in pregnancyBlood - Anaemia
- Registration Number
- ACTRN12609000177257
- Lead Sponsor
- aunceston General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
This trial will be available to all women planning confinement at the Launceston General Hospital (LGH) over a period of 18-24 months. Pregnant women who are anaemic with Hb level <116g/L and 18 year old and above are eligible for this study.
Exclusion Criteria
Cause of anaemia other than Iron deficiency:Malabsorption syndrome affecting uptake of oral iron Condition associated with iron overload e.g. Haemochromatosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Haemoglobin (Hb) level pre-delivery via full blood count test[Haemoglobin (Hb) level at 4 weeks after treatment]
- Secondary Outcome Measures
Name Time Method To assess quality of life of pregnant women via regular questionnaires designed for the purpose of study at the Launceston General Hospital[after 4 weeks of treatment and pre as well as Post delivery follow up];Amount of blood transfusion. Via reviewing hospital records.[40 weeks gestation and post delivery.];Estimate any additional cost versus benefit of intravenous iron over oral iron.[by delivery time (40 weeks)]